Xentria Highlights New Episode of Lifetime® TV’s “Behind the Mystery” Segment of “The Balancing Act®” on Sarcoidosis
December 14, 2021
CHICAGO–(BUSINESS WIRE)–Xentria Inc., a biotech company focused on developing novel biologics to address unmet clinical needs, today highlighted a new sarcoidosis episode of The Balancing Act airing on Lifetime on a specialized, recurring segment devoted to rare and genetic diseases. The live segment, which aired at 7:30 a.m. ET this morning, follows the unique diagnosis and treatment journey of a sarcoidosis patient and provides clinical insights from Dr. Peter Sporn, Director of the Sarcoidosis Center of Excellence at Northwestern Medicine in Chicago, regarding this rare and difficult to treat disease. The episode will be rebroadcast on December 14th, 2021 at 7:30 a.m. (ET/PT) on Lifetime TV.
Help for those with COPD, promising news for our four-legged friends suffering from cancer, and a non-invasive way to sculpt our bodies.
ELIAS Animal Health's mission is to improve cancer treatment outcomes in veterinary patients through the advancement of innovative, scientifically-proven therapies.
Body sculpting does not have to be an invasive and taxing procedure. AirSculpt is a next-generation body contouring technology that removes and transfers fat using patented technology.